K L Laugwitz

ISAR-SAFE: a randomized, double-blind, placebo-controlled trial of 6 vs. 12 months of clopidogrel therapy after drug-eluting stenting

Stefanie Schüpke, Robert A. Byrne, Jurriën M. ten Berg et al. · European Heart Journal · 2015 · 429 citations · Full text

Medicine, Cardiology, Pharmacotherapy +17

PET/MRI early after myocardial infarction: evaluation of viability with late gadolinium enhancement transmurality vs. 18F-FDG uptake

Christoph Rischpler, N. Langwieser, Michael Souvatzoglou et al. · European Heart Journal - Cardiovascular Imaging · 2015 · 104 citations

Medicine, Nuclear Medicine, Radiology +17

Randomised trial of three rapamycin-eluting stents with different coating strategies for the reduction of coronary restenosis: 2-year follow-up results

Robert A. Byrne, Sebastian Kufner, Klaus Tiroch et al. · Heart · 2009 · 96 citations

Medicine, Cardiology, Pharmacotherapy +17

ISAR-REACT 3A: a study of reduced dose of unfractionated heparin in biomarker negative patients undergoing percutaneous coronary intervention

S. Schulz, Julinda Mehilli, F.-J. Neumann et al. · European Heart Journal · 2010 · 85 citations · Full text

Medicine, Cardiology, Pharmacology +17

Biology of Isl1+ cardiac progenitor cells in development and disease.

Alessandra Moretti, Jenny K.W. Lam, Sue Evans et al. · PubMed · 2007 · 42 citations · Full text

Life Sciences, Cell Biology, Developmental Biology +12